Outside actors already moving: management's forward story is carried by at least two independent external parties whose
The model's full reasoning — Q4 2017 call → NOWe need answer YES/NO based on transcript. Need analyze. Question: On this call, when management explains why the company's business is about to be meaningfully larger, is that explanation carried primarily by the ALREADY-TAKEN ACTIONS OF EXTERNAL PARTIES — and are there AT LEAST TWO SEPARATE such external parties or party groups whose actions management describes as already underway, with the resulting business only beginning to appear in the reported results? Need evaluate transcript. Company Insmed, developing ALIS for NTM. They have Phase III results, NDA filing, precommercial activities. Business about to be meaningfully larger? They are pre-revenue, expect launch end 2018. Management explains growth? They discuss clinical trial results, regulatory filing, hiring sales force, manufacturing, etc. External parties? FDA? Payers? Physicians? Patients? But question asks "already-taken actions of external parties" that are already underway and business only beginning to appear in reported results. Need identify at least two separate external parties whose actions management describes as already underway. Examples: FDA? Not yet approved. Payers? They are conducting pricing research, not commitments. Physicians? They hired field team to educate, but not yet prescribing. Patients? Clinical trial participants? Not external business actions. Maybe "external parties" could be regulatory authorities? But actions are not yet taken? Let's parse. Management says "We have made tremendous progress... 2018 will be the year we secure approval and launch...". They have positive topline results, NDA filing on track. They are building commercial organization. They hired therapeutic specialists, key account directors, patient support infrastructure, producing commercial batches, third-party manufacturing site with Patheon. But these are company's own initiatives. External parties? Patheon is a partner for manufacturing, but that's not business growth from customers. Payers? They are engaging with payers, but no commitments. Physicians? They will begin meeting with targeted physicians in mid-March to educate. Not already taken actions. FDA? They expect advisory committee, but not yet. The only external actions already taken? Maybe patients in clinical trials? Not business.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
MEC · Q3 2022 → YESThe question is about whether management explains why the company's business is about to be meaningfully larger based on already-taken actions of external parties, with at least two separate such part...YES The transcript shows management attributing meaningful future growth primarily to external customer actions already taken: specific awards and wins (e.g., large family of parts for electric side-by-side with full 2023 launch; high-value takeover project for ag customer; reshoring project closed for commercial vehicle customer starting early 2023; 2023 production ramp at Hazel Park facility; incremental business from light-duty truck platform). These are concrete, past-tense commitments from distinct customers (existing side-by-side customer, ag customer, commercial vehicle customer, light-duty truck engine manufacturer, new industrial infrastructure customer), with volumes and ramps explicitly described as beginning in 202 3 and continuing into coming quarters.
EVGO · Q2 2022 → YESThe question is about whether management explains why the business is about to be meaningfully larger based on already-taken actions of external parties, with at least two separate such parties, and t...YES The transcript shows management framing the company's growth as driven by external parties' already-completed actions: the GM-Pilot partnership (signed and announced, with EVgo to procure/construct/operate/maintain up to 2,000 stalls and 500 locations, delivering near-term revenue and contracted cash flows), the 2023 Cadillac LYRIQ charging offer (commercial agreement signed), the Philadelphia municipal fleet partnership (announced and operational), the GSA BPA award (five-year blanket purchase agreement now in place for federal agencies), and the California Energy Commission grant (selected for $3.6 million to build fast charging).
PRIM · Q2 2018 → YESThe question is about whether management explains why the business is about to be meaningfully larger based on already-taken actions of at least two separate external parties, and the reported results...YES The transcript shows management framing the business as about to become meaningfully larger primarily through external parties' already-completed actions: (1) the Willbros acquisition closed June 1, 2018, with Willbros now contributing $61 million revenue and $6.8 million gross profit in June alone (one month 2018 results), and (2) three separate major customers—previously hesitant due to Willbros' prior financial concerns—have now awarded work to the newly acquired T&D Group, with the largest MSA award announced and two additional awards leaking out, all within the first two months post-acquisition.